Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 11/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.32 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21351829 | 0.90 | BRD4 (0.39) | BRD4THRBMAPTATM | |
| SCHEMBL21351835 | 0.89 | BRD4 (0.36) | BRD4THRBMAPTMAPK14 | |
| SCHEMBL21362108 | 0.89 | BRD4 (0.36) | BRD4THRBMAPTMAPK14 | |
| SCHEMBL21354474 | 0.89 | BRD4 (0.36) | BRD4THRBMAPTMAPK14 | |
| SCHEMBL21351838 | 0.89 | BRD4 (0.36) | BRD4THRBMAPTMAPK14 | |
| SCHEMBL21352206 | 0.89 | BRD4 (0.36) | BRD4THRBMAPTMAPK14 | |
| SCHEMBL21352183 | 0.89 | BRD4 (0.36) | BRD4THRBMAPTMAPK14 | |
| SCHEMBL21362109 | 0.88 | BRD4 (0.36) | BRD4THRBMAPT | |
| SCHEMBL21362106 | 0.88 | BRD4 (0.36) | BRD4THRBMAPT | |
| SCHEMBL20157926 | 0.87 | BRD4 (0.37) | BRD4MAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3539960-A1 | NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) | 2019-09-18 | — | — | EP | disclosed |